Concepedia

Fumiko Axelrod

FA

12

Publications

2.4K

Citations

12

H-Index

1992

Active since

Affiliations

OncoMed (United States)(Current)

Twist Bioscience (United States)

University of California San Diego

Sanford Burnham Prebys Medical Discovery Institute

Fumiko Axelrod is an author at OncoMed (United States) specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

1992–2023

12

Publications

12

Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors

Austin Gurney, Fumiko Axelrod, Christopher J. Bond et al. · Proceedings of the National Academy of Sciences · 2012 · 618 citations · Full text

, , +21

Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity

Steven J. Kridel, Fumiko Axelrod, Natasha Rozenkrantz et al. · Cancer Research · 2004 · 589 citations · Full text

DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency

Timothy Hoey, Wan-Ching Yen, Fumiko Axelrod et al. · Cell stem cell · 2009 · 397 citations · Full text

, , +7

Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency

Wan-Ching Yen, Marcus Fischer, Fumiko Axelrod et al. · Clinical Cancer Research · 2015 · 239 citations

A Fatty Acid Synthase Blockade Induces Tumor Cell-cycle Arrest by Down-regulating Skp2

Lynn M. Knowles, Fumiko Axelrod, Cecille D. Browne et al. · Journal of Biological Chemistry · 2004 · 145 citations · Full text

Rows per page

1–5 of 12